骨髓增生-话题@MedSci

#骨髓增生#

95篇内容 | 979人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1821741, encodeId=1d591821e41fa, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Br J Haematol：日本公共卫生中心的研究表明——吸烟和饮酒与骨髓增生异常综合征风险的影响不同（前瞻性研究）, objectType=article, longId=105929, objectId=db961059298d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db961059298d, replyNumber=0, likeNumber=40, createdTime=2018-03-31, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db961059298d, moduleTitle=Br J Haematol：日本公共卫生中心的研究表明——吸烟和饮酒与骨髓增生异常综合征风险的影响不同（前瞻性研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db961059298d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821745, encodeId=403d1821e45b1, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Int J Cancer：咖啡和绿茶真的能降低急性髓系白血病和骨髓增生异常综合征的风险吗？, objectType=article, longId=118356, objectId=425b118356fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=425b118356fe, replyNumber=0, likeNumber=44, createdTime=2018-08-21, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=425b118356fe, moduleTitle=Int J Cancer：咖啡和绿茶真的能降低急性髓系白血病和骨髓增生异常综合征的风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=425b118356fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821744, encodeId=37b31821e44f2, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=2017 日本造血和淋巴组织肿瘤指南：慢性粒细胞白血病/骨髓增生性肿瘤, objectType=article, longId=115285, objectId=810a1152853d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=810a1152853d, replyNumber=0, likeNumber=13, createdTime=2018-03-24, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=810a1152853d, moduleTitle=2017 日本造血和淋巴组织肿瘤指南：慢性粒细胞白血病/骨髓增生性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=810a1152853d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821737, encodeId=c8b41821e37c5, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=NEJM：骨髓增生异常综合征进行干细胞移植后的预后相关因素, objectType=article, longId=88537, objectId=485a8853e67, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=485a8853e67, replyNumber=0, likeNumber=34, createdTime=2017-10-27, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=485a8853e67, moduleTitle=NEJM：骨髓增生异常综合征进行干细胞移植后的预后相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=485a8853e67)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821735, encodeId=d31c1821e359e, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=2017 NCCN临床实践指南：骨髓增生异常综合征（2017.V2）, objectType=article, longId=83253, objectId=95eb8325387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95eb8325387, replyNumber=0, likeNumber=18, createdTime=2016-12-28, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95eb8325387, moduleTitle=2017 NCCN临床实践指南：骨髓增生异常综合征（2017.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95eb8325387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821738, encodeId=b0671821e3812, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=JCO：阿扎胞苷单药或与来那度胺或伏立诺他联合用药治疗高风险骨髓增生异常综合征或慢性单核细胞白血病, objectType=article, longId=98626, objectId=ca039862681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca039862681, replyNumber=0, likeNumber=38, createdTime=2017-09-10, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca039862681, moduleTitle=JCO：阿扎胞苷单药或与来那度胺或伏立诺他联合用药治疗高风险骨髓增生异常综合征或慢性单核细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca039862681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821734, encodeId=208e1821e3425, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=2017NCCN临床实践指南——骨髓增生异常综合征（2017.V1）, objectType=article, longId=75750, objectId=0297e5750ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0297e5750ca, replyNumber=0, likeNumber=22, createdTime=2016-10-22, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0297e5750ca, moduleTitle=2017NCCN临床实践指南——骨髓增生异常综合征（2017.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0297e5750ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821733, encodeId=23a21821e336a, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=JCO：来那度胺可延长一些骨髓增生异常综合征患者的输血依赖, objectType=article, longId=72952, objectId=4647e2952d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4647e2952d3, replyNumber=0, likeNumber=39, createdTime=2017-02-01, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4647e2952d3, moduleTitle=JCO：来那度胺可延长一些骨髓增生异常综合征患者的输血依赖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4647e2952d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821732, encodeId=32d91821e324f, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=J Clin Oncol：骨髓增生异常综合征患者移植后预后评分系统, objectType=article, longId=69903, objectId=a50469903e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a50469903e8, replyNumber=0, likeNumber=34, createdTime=2016-07-01, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a50469903e8, moduleTitle=J Clin Oncol：骨髓增生异常综合征患者移植后预后评分系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a50469903e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821736, encodeId=3b8e1821e36db, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=2017 NCCN临床实践指南：骨髓增生异常综合征-证据块（2017.V2）, objectType=article, longId=83254, objectId=b2398325495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2398325495, replyNumber=0, likeNumber=22, createdTime=2016-12-26, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2398325495, moduleTitle=2017 NCCN临床实践指南：骨髓增生异常综合征-证据块（2017.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2398325495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821731, encodeId=379d1821e319c, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Lancet Oncol：疲劳评估对骨髓增生异常综合征等患者的总生存期有预后价值, objectType=article, longId=56519, objectId=63bc5651986, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63bc5651986, replyNumber=0, likeNumber=29, createdTime=2016-07-29, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63bc5651986, moduleTitle=Lancet Oncol：疲劳评估对骨髓增生异常综合征等患者的总生存期有预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63bc5651986)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821730, encodeId=b9681821e3071, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=GSK启动eltrombopag骨髓增生异常综合症III期SUPPORT研究, objectType=article, longId=37292, objectId=978e3e292c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=978e3e292c3, replyNumber=0, likeNumber=24, createdTime=2015-04-27, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=978e3e292c3, moduleTitle=GSK启动eltrombopag骨髓增生异常综合症III期SUPPORT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=978e3e292c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821729, encodeId=d2a81821e29ef, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=再生障碍性贫血与低增生性骨髓增生异常综合征鉴别诊断思路, objectType=article, longId=26438, objectId=cb9f26438e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb9f26438e1, replyNumber=0, likeNumber=32, createdTime=2013-11-21, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb9f26438e1, moduleTitle=再生障碍性贫血与低增生性骨髓增生异常综合征鉴别诊断思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb9f26438e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821727, encodeId=add31821e2768, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=2012中国“骨髓增生异常综合征诊疗共识”发布（附下载）, objectType=article, longId=5748, objectId=66cf5e4822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66cf5e4822, replyNumber=0, likeNumber=42, createdTime=2012-07-03, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66cf5e4822, moduleTitle=2012中国“骨髓增生异常综合征诊疗共识”发布（附下载）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66cf5e4822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821728, encodeId=edfa1821e280d, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=J mmunol：调节性T细胞可预测骨髓增生异常综合征, objectType=article, longId=9768, objectId=e0e49e6858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0e49e6858, replyNumber=0, likeNumber=38, createdTime=2012-10-17, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0e49e6858, moduleTitle=J mmunol：调节性T细胞可预测骨髓增生异常综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0e49e6858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821726, encodeId=b6671821e2621, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=JCO：ASXL1突变预测骨髓增生异常综合征转归不良, objectType=article, longId=2603, objectId=f86a260341, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f86a260341, replyNumber=0, likeNumber=26, createdTime=2011-11-29, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f86a260341, moduleTitle=JCO：ASXL1突变预测骨髓增生异常综合征转归不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f86a260341)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

骨髓增生

2020-05-29

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Br J Haematol：日本公共卫生中心的研究表明——吸烟和饮酒与骨髓增生异常综合征风险的影响不同（前瞻性研究）

2018-03-31

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Int J Cancer：咖啡和绿茶真的能降低急性髓系白血病和骨髓增生异常综合征的风险吗？

2018-08-21

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

2017 日本造血和淋巴组织肿瘤指南：慢性粒细胞白血病/骨髓增生性肿瘤

2018-03-24

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

NEJM：骨髓增生异常综合征进行干细胞移植后的预后相关因素

2017-10-27

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

2017 NCCN临床实践指南：骨髓增生异常综合征（2017.V2）

2016-12-28

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

JCO：阿扎胞苷单药或与来那度胺或伏立诺他联合用药治疗高风险骨髓增生异常综合征或慢性单核细胞白血病

2017-09-10

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

2017NCCN临床实践指南——骨髓增生异常综合征（2017.V1）

2016-10-22

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

JCO：来那度胺可延长一些骨髓增生异常综合征患者的输血依赖

2017-02-01

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

J Clin Oncol：骨髓增生异常综合征患者移植后预后评分系统

2016-07-01

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

2017 NCCN临床实践指南：骨髓增生异常综合征-证据块（2017.V2）

2016-12-26

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Lancet Oncol：疲劳评估对骨髓增生异常综合征等患者的总生存期有预后价值

2016-07-29

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

GSK启动eltrombopag骨髓增生异常综合症III期SUPPORT研究

2015-04-27

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

再生障碍性贫血与低增生性骨髓增生异常综合征鉴别诊断思路

2013-11-21

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

2012中国“骨髓增生异常综合征诊疗共识”发布（附下载）

2012-07-03

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

J mmunol：调节性T细胞可预测骨髓增生异常综合征

2012-10-17

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

JCO：ASXL1突变预测骨髓增生异常综合征转归不良

2011-11-29

科室
- - 订阅+
  - 更多科室
工具
服务